newsfilter
← Latest News
GlobeNewswire·

MannKind to Participate in Upcoming Investor Conferences

  • MannKind Corporation CEO Michael Castagna & CFO Chris Prentiss will provide a business update at two upcoming investor conferences in London.
  • The UBS Global Biopharma Conference fireside chat is scheduled for Tuesday, November 17, 2026, from 11:20 to 11:50 a.m. GMT.
  • The Jefferies Global Healthcare Conference presentation is scheduled for Wednesday, November 18, 2026, from 8:00 to 8:25 p.m. GMT.
  • Live webcasts will be available on MannKind's Investor Relations website, with replays accessible for approximately 90 days post-event.
  • MannKind is a biopharmaceutical company focused on developing drug-device combinations for cardiometabolic & orphan lung diseases, including diabetes, pulmonary hypertension, & fluid overload in heart failure or chronic kidney disease.
Company
MannKind
Keywords
Nasdaq:MNKD, MannKind, WEBCAST